Señales en vivo de 086900.KQ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 02:30):

Stats
Volumen de hoy	27 451.00
Volumen promedio	70 533.00
Capitalización de mercado	928.77B
EPS	KRW0 ( 2024-03-06 )
Próxima fecha de ganancias	( KRW2 255.00 ) 2024-05-13
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW52.07 (0.04%)

Volumen Correlación

Largo: -0.08 (neutral)

Corto: 0.38 (neutral)

Signal:(40.535) Neutral

Medy-Tox Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medy-Tox Inc. Correlación - Moneda/Commodity

-0.46
( neutral )

-0.32
( neutral )

-0.18
( neutral )

-0.31
( neutral )

-0.29
( neutral )

0.58
( weak )

Medy-Tox Inc. Finanzas

Annual	2023
Ingresos:	KRW221.12B
Beneficio Bruto:	KRW128.16B (57.96 %)
EPS:	KRW1 311.06

FY	2023
Ingresos:	KRW221.12B
Beneficio Bruto:	KRW128.16B (57.96 %)
EPS:	KRW1 311.06

FY	2022
Ingresos:	KRW195.10B
Beneficio Bruto:	KRW124.14B (63.63 %)
EPS:	KRW5 491.68

Financial Reports:

No articles found.

Medy-Tox Inc.

Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles; and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles. The company also offers hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials. In addition, it provides various medical devices, such as ComfortDual and Recell Ice for tissue coagulation by using high-frequency current; Neurajet Plus to assist injecting other pharmaceuticals; Carewave for improving erectile dysfunction by using low-intensity shock wave generated from the electromagnetic method; and Careveam for treating skin ailment by using ultraviolet light. Further, the company offers Neurakin cream for acute eczema, contact dermatitis, atopic dermatitis, chronic eczema, rosacea dermatitis, perioral dermatitis, herpes zoster, and acne vulgaris. It also exports its products to approximately 60 countries, including Japan, Thailand, and Brazil. Medytox, Inc. has partnership with Dyadic International, Inc. to develop vaccines against COVID-19 variants. The company was founded in 2000 and is headquartered in Cheongju, South Korea.